JW (Cayman) Therapeutics Co. Ltd (2126.HK)
HKD 1.58
(3.27%)
HKD 1.58
(3.27%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 462.25 Million CNY | 5.76% |
| 2022 | 437.06 Million CNY | 34.17% |
| 2021 | 325.74 Million CNY | -6.86% |
| 2020 | 349.75 Million CNY | -78.29% |
| 2019 | 1.61 Billion CNY | 146.32% |
| 2018 | 654.02 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 497.87 Million CNY | 0.0% |
| 2023 Q2 | 552.3 Million CNY | 0.0% |
| 2023 Q4 | 462.25 Million CNY | 0.0% |
| 2023 FY | 462.25 Million CNY | 5.76% |
| 2022 FY | 437.06 Million CNY | 34.17% |
| 2022 Q4 | 490.7 Million CNY | 0.0% |
| 2022 Q2 | 343.48 Million CNY | 0.0% |
| 2021 Q4 | 398.47 Million CNY | 0.0% |
| 2021 Q2 | 368.78 Million CNY | 0.0% |
| 2021 FY | 325.74 Million CNY | -6.86% |
| 2020 FY | 349.75 Million CNY | -78.29% |
| 2020 Q4 | 414.68 Million CNY | 0.0% |
| 2020 Q2 | 3.23 Billion CNY | 0.0% |
| 2019 Q4 | 1.8 Billion CNY | 0.0% |
| 2019 FY | 1.61 Billion CNY | 146.32% |
| 2019 Q2 | - HKD | 0.0% |
| 2018 FY | 654.02 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 152.81 Million HKD | -202.49% |
| CK Life Sciences Int'l., (Holdings) Inc. | 7.05 Billion HKD | 93.451% |